Combined Diagnostic Approach for Refractory Mycoplasma Pneumonia in Children
Status:
COMPLETED
Trial end date:
2024-05-31
Target enrollment:
Participant gender:
Summary
This study evaluates whether a combined approach using bronchoscopy, chest CT scoring, and monocyte subpopulation analysis can improve clinical outcomes for children with refractory Mycoplasma pneumoniae pneumonia (RMPP) when compared to conventional treatment. The goal is to determine if this multi-dimensional assessment can lead to more personalized and effective treatment, resulting in shorter recovery times, lower recurrence rates, and better quality of life.
Phase:
NA
Details
Lead Sponsor:
Children's Hospital of Hebei Province
Treatments:
Azithromycin Bronchoalveolar Lavage Doxycycline Palliative Care Prednisone